Evidence map›Paper›PMID 11401832›Full record

ArticleAmerican journal of physiology. Cell physiology2001

[Ca2+]i as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen.

L Hodgson, C Dong

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. The Role of Calcium Signaling in Melanoma.International journal of molecular sciences · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. PDGF receptor-{beta} modulates metanephric mesenchyme chemotaxis induced by PDGF AA.American journal of physiology. Renal physiology · 2009
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

L HodgsonDepartment of Bioengineering, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
C Dong
Pennsylvania State University · US

Funding

SIGNAL TRANSDUCTION AND MOTILITY IN TUMOR CELL MIGRATIONR29CA076434 · NCI · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI DONG, CHENG · 1998 to 2002
$295k
NCI NIH HHS CA-76434NCI NIH HHS R29 CA076434
6 · The paper itself

Abstract

We have investigated cellular Ca2+ regulation during A2058 human melanoma cell chemotaxis to type IV collagen (CIV). We have identified alpha2beta1-integrin as the primary mediator of A2058 cell response to CIV in vitro. Integrin ligation initiated a characteristic intracellular Ca2+ concentration ([Ca2+]i) response consisting of an internal release and a receptor-mediated Ca2+ entry. Thapsigargin (TG) pretreatment drained overlapping and CIV-inducible internal Ca2+ stores while initiating a store-operated Ca2+ release (SOCR). CIV-mediated Ca2+ entry was additive to TG-SOCR, suggesting an independent signaling mechanism. Similarly, ionophore application in a basal medium containing Ca2+ initiated a sustained influx. Elevated [Ca2+]i from TG-SOCR or ionophore significantly attenuated cell migration to CIV by recruiting the Ca2+/calcineurin-mediated signaling pathway. Furthermore, low [Ca2+]i induced by EGTA application in the presence of ionophore fully restored cell motility to CIV. Together, these results suggest that [Ca2+]i signaling accompanying A2058 cell response to alpha2beta1-integrin ligation is neither necessary nor sufficient and that elevated [Ca2+]i downregulates cell motility via a calcineurin-mediated mechanism in A2058 cell chemotaxis to CIV.

Indexed as

Antibodies, MonoclonalCalcimycinCalcineurinCalciumCalcium SignalingChelating AgentsChemotaxisCollagenCulture Media, Serum-FreeEgtazic AcidEnzyme InhibitorsHumansIntegrinsIonophoresMelanomaReceptors, CollagenAntibodies, MonoclonalCalcimycinCalcineurinCalciumChelating AgentsCollagenCulture Media, Serum-FreeEgtazic AcidEnzyme InhibitorsIntegrinsIonophoresReceptors, CollagenThapsigargin

Identifiers

PMID11401832
PMCPMC2796124
OpenAlexW2151893454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.